HYFT
ImmunoPrecise Antibodies Ltd.
1.30$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in CAD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.21 | 0.95 | 0.66 | 0.60 | 0.87 | 1.08 | 1.09 | 0.98 | 0.83 | 0.96 | 0.73 | 0.33 | |
| 0.00 | 0.00 | 0.31 | 0.33 | 0.45 | 1.12 | 0.39 | 0.43 | 0.37 | 0.49 | 0.33 | 0.14 | |
| 0.00 | 0.00 | 0.36 | 0.27 | 0.42 | -0.04 | 0.70 | 0.56 | 0.46 | 0.47 | 0.41 | 0.19 | |
| 1.13 | 0.15 | 0.17 | 0.06 | 0.04 | 0.03 | 0.12 | 0.39 | 0.57 | 0.16 | 0.15 | 0.10 | |
| 0.12 | 0.50 | 0.47 | 0.62 | 0.58 | 0.58 | 0.76 | 0.78 | 0.62 | 0.61 | 0.44 | 0.41 | |
| 0.12 | 0.83 | 0.71 | 0.81 | 0.92 | 0.27 | 0.95 | 1.40 | 1.49 | 1.01 | 0.77 | 0.51 | |
| -0.12 | 0.12 | -0.35 | -0.54 | -0.50 | -0.31 | -0.25 | -0.85 | -1.03 | -0.54 | -0.37 | -0.32 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.07 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.11 | 0.12 | -1.38 | -0.56 | -0.61 | -0.41 | -0.36 | -0.80 | -1.11 | -1.12 | -1.03 | -0.33 | |
| 0.00 | 0.05 | -0.02 | 0.01 | 0.00 | -0.03 | 0.08 | 0.04 | -0.05 | -0.10 | -0.12 | -0.01 | |
| -0.11 | 0.08 | -1.36 | -0.57 | -0.61 | -0.38 | -0.45 | -0.85 | -1.07 | -1.02 | -0.91 | -0.30 | |
| -0.11 | 0.15 | -1.36 | -0.48 | -0.32 | -0.09 | -0.09 | -0.61 | -0.84 | -0.90 | -0.86 | -0.28 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.